Clinical trials
Liver Cirrhosis trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 21 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 14 |
| Yonsei University | 6 |
| Seoul National University Boramae Hospital | 5 |
| Chuncheon Sacred Heart Hospital | 4 |
| Asan Medical Center | 2 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| Korea University | 2 |
| Atea Pharmaceuticals, Inc. | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 58 |
| Carcinoma, Hepatocellular | 12 |
| Fibrosis | 5 |
| Hypertension, Portal | 5 |
| Ascites | 4 |
| Hepatitis B, Chronic | 4 |
| Fatty Liver | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Acute Kidney Injury | 2 |
| Diabetes Mellitus | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.